Akorn Enters Into Exclusive Vaccine Partnership With Serum Institute of India

November 2, 2007

Akorn and Serum Institute of India, a privately-held worldwide leader in vaccines and the world’s largest manufacturer of Measles and Diphtheria Tetanus Pertussis vaccines, announced the signing of an Exclusive Memorandum of Understanding with an intent to commercialize six vaccines for the U.S. market.
Business Wire